We are live on ! Find out more
GILD icon

Gilead Sciences
GILD

1,678 hedge funds and large institutions have $71.8B invested in Gilead Sciences in 2024 Q2 according to their latest regulatory filings, with 130 funds opening new positions, 649 increasing their positions, 687 reducing their positions, and 150 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more call options, than puts

Call options by funds: $1.02B | Put options by funds: $726M

0% more funds holding in top 10

Funds holding in top 10: 14 → 14 (0)

0.12% less ownership

Funds ownership: 83.43% → 83.31% (-0.12%)

6% less repeat investments, than reductions

Existing positions increased: 649 | Existing positions reduced: 687

2% less funds holding

Funds holding: 1,721 → 1,678 (-43)

6% less capital invested

Capital invested by funds: $76.1B → $71.8B (-$4.3B)

13% less first-time investments, than exits

New positions opened: 130 | Existing positions closed: 150

Holders
1,678
Holders Change
-43
Holders Change %
-2.5%
% of All Funds
24.23%
Holding in Top 10
14
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.2%
New
130
Increased
649
Reduced
687
Closed
150
Calls
$1.02B
Puts
$726M
Net Calls
+$291M
Net Calls Change
+$247M

Top Buyers

1
Goldman Sachs
Goldman Sachs
New York
+$266M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$158M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$147M
4
Millennium Management
Millennium Management
New York
+$132M
5
Swedbank
Swedbank
Sweden
+$124M

Top Sellers

1
Capital World Investors
Capital World Investors
California
-$550M
2
Citadel Advisors
Citadel Advisors
Florida
-$337M
3
N
Nuveen
North Carolina
-$239M
4
Barclays
Barclays
United Kingdom
-$144M
5
BlackRock
BlackRock
New York
-$127M
Name Holding Trade Value Shares
Change 		Change in
Stake
AllianceBernstein
26
AllianceBernstein
Tennessee
$458M -$20.1M -301,300 -4%
Bank of America
27
Bank of America
North Carolina
$458M +$3.92M +58,754 +0.9%
Manulife (Manufacturers Life Insurance)
28
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$453M -$35.3M -529,237 -7%
California Public Employees Retirement System
29
California Public Employees Retirement System
California
$437M -$79.1M -1,185,503 -16%
Royal Bank of Canada
30
Royal Bank of Canada
Ontario, Canada
$437M -$50.8M -761,687 -11%
Federated Hermes
31
Federated Hermes
Pennsylvania
$434M +$69.2M +1,036,932 +20%
VanEck Associates
32
VanEck Associates
New York
$434M +$49.9M +747,831 +13%
Two Sigma Advisers
33
Two Sigma Advisers
New York
$429M +$78.5M +1,176,100 +23%
LSV Asset Management
34
LSV Asset Management
Illinois
$378M -$11.1M -166,860 -3%
Bank of Montreal
35
Bank of Montreal
Ontario, Canada
$370M +$50.3M +753,545 +21%
HSBC Holdings
36
HSBC Holdings
United Kingdom
$366M +$57M +853,524 +19%
Renaissance Technologies
37
Renaissance Technologies
New York
$347M +$49.4M +739,948 +17%
N
38
Nuveen
North Carolina
$342M -$239M -3,584,153 -42%
ClearBridge Investments
39
ClearBridge Investments
New York
$328M -$3.77M -56,526 -1%
Barclays
40
Barclays
United Kingdom
$319M -$144M -2,151,007 -32%
Arrowstreet Capital
41
Arrowstreet Capital
Massachusetts
$315M -$30.8M -461,229 -9%
UBS Group
42
UBS Group
Switzerland
$309M +$18.9M +282,831 +7%
Allianz Asset Management
43
Allianz Asset Management
Germany
$289M -$6.35M -95,091 -2%
Aberdeen Group
44
Aberdeen Group
United Kingdom
$284M +$13.3M +199,779 +5%
First Trust Advisors
45
First Trust Advisors
Illinois
$274M -$12.8M -192,379 -5%
Swiss National Bank
46
Swiss National Bank
Switzerland
$253M -$2.64M -39,500 -1%
KBC Group
47
KBC Group
Belgium
$249M +$31.2M +468,039 +15%
Robeco Institutional Asset Management
48
Robeco Institutional Asset Management
Netherlands
$239M -$6.41M -96,067 -3%
D.E. Shaw & Co
49
D.E. Shaw & Co
New York
$229M +$147M +2,203,342 +194%
Two Sigma Investments
50
Two Sigma Investments
New York
$229M +$9.14M +136,934 +4%
1
2
3 4 5

GILD Hedge Fund Activity: Q2 2024 in Review

1,678 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Gilead Sciences (GILD) for Q2 2024, worth a combined $71.8B — down 5.6% from $76.1B a quarter earlier.

Sellers outnumbered buyers: 150 funds closed out of GILD and 130 opened new positions — a net loss of 20 holders — while 687 trimmed existing stakes and 649 added.

The largest buyer was Goldman Sachs, adding an estimated $266M. The largest seller was Capital World Investors, cutting an estimated $550M.

  • 1,678 institutional investors held Gilead Sciences (GILD) as of Q2 2024, down from 1,721 in Q1 2024.
  • Funds reported $71.8B of Gilead Sciences stock for Q2 2024, down 5.6% quarter-over-quarter.
  • 130 funds opened new Gilead Sciences positions in Q2 2024 and 150 closed out, a net change of -20 holders.
  • The largest Gilead Sciences buyer in Q2 2024 was Goldman Sachs, an estimated $266M added.
  • The largest Gilead Sciences seller in Q2 2024 was Capital World Investors, an estimated $550M sold.

Based on aggregated 13F filings for Q2 2024.